Have a great day!
AusCann is an Australian based company that was incorporated in September 2014 with the
aim of producing and providing high quality, economical and clinically validated cannabis
medicines to patients. It is bringing together leading expertise and operations across all
aspects of the medical cannabis value chain, beginning with cultivation and production,
through to manufacture and distribution of products and has built a strong team of experts
and partners with international connections. Partners includes TSX listed Canopy Growth
Corporations the largest producer of medicinal cannabis globally and DayaCann, the only
licensed medicinal cannabis grower in Chile.
Auscann Group’s shares surge following green light for medicinal cannabis export
Tas Alks considers expanding medicinal cannabis project for export
Toronto – Toronto Delayed Price. Currency in CA $34.00+1.68(+5.20%) At close: January 5 4:47PM EST
OUR CORE BRANDS
Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.
Spectrum Cannabis is Canopy Growth’s international medical brand, serving as the Company’s healthcare professional and patient-facing identity in medical markets in Canada and around the world. Spectrum Cannabis is focused on the simplification of healthcare interactions, stakeholder outreach, and patient education, applying a colour-coded Spectrum to classify cannabis that tens of thousands of Canadians rely on each day. With a presence in multiple jurisdictions across several continents, our industry-leading expertise developed in Canada is now available around the world through the Spectrum Cannabis brand.
Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.